[ Price : $8.95]
An FDA advisory committee briefing document says Mercks oral antiviral molnupiravir is associated with a relative risk reduction ...[ Price : $8.95]
Federal Register notice: FDA determines for patent extension purposes the regulatory review period for Immunomedics breast cancer ...[ Price : $8.95]
FDA warns Minneapolis-based Smiths Medical about Medical Device Reporting and Quality System violations in its work as a specifica...[ Price : $8.95]
FDA schedules a 12/14 Webinar on the medical device de novo classification process and its guidance document updates.[ Price : $8.95]
The Justice Department says a French national has been charged with making false statements to FDA to fraudulently obtain control ...[ Price : $8.95]
FDA grants Pear Therapeutics a breakthrough device designation for its reSET-A PDT (Prescription Digital Therapeutic) product cand...[ Price : $8.95]
FDA warns Scottsdale, AZ-based Surgenex about CGMP and other violations in its production and distribution of cellular products fo...[ Price : $8.95]
Federal Register notice: FDA proposes to reclassify human immunodeficiency virus viral load monitoring tests from Class 3 to Class...